Abstract
Nucleolar and spindle-associated protein (NUSAP1) is a microtubule and chromatin-binding protein that stabilizes microtubules to prevent depolymerization, maintains spindle integrity. NUSAP1 could cross-link spindles into aster-like structures, networks and fibers. It has also been found to play roles in progression of several cancers. However, the potential correlation between NUSAP1 and clinical outcome in patients with glioblastoma multiforme (GBM) remains largely unknown. In the current study, we demonstrated that NUSAP1 was significantly up-regulated in GBM tissues compared with adult non-tumor brain tissues both in a validated cohort and a TCGA cohort. In addition, Kaplan–Meier analysis indicated that patients with high NUSAP1 expression had significantly lower OS (P = 0.0027). Additionally, in the TCGA cohort, NUSAP1 expression was relatively lower in GBM patients within the neural and mesenchymal subtypes compared to other subtypes, and associated with the status of several genetic aberrations such as PTEN deletion and wild type IDH1. The present study provides new insights and evidence that NUSAP1 over-expression was significantly correlated with progression and prognosis of GBM. Furthermore, knockdown of NUSAP1 revealed its regulation on G2/M progression and cell proliferation (both in vitro and in vivo). These data demonstrate that NUSAP1 could serve as a novel prognostic biomarker and a potential therapeutic target for GBM.
Similar content being viewed by others
Abbreviations
- GBM:
-
Glioblastoma multiforme
- NUSAP1:
-
Nucleolar-spindle associated protein
- TCGA:
-
The Cancer Genome Atlas
- CNS:
-
Central nervous system
- SPF:
-
Specific pathogen-free
- shRNA:
-
Short hairpin RNA
- qRT-PCR:
-
Quantitative real-time polymerase chain reaction
References
Ostrom QT, Gittleman H, Farah P et al (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol Suppl 2:ii1–ii56
Westphal M, Lamszus K (2011) The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci 12:495–508
Gilbert MR, Dignam JJ, Armstrong TS et al (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 370:699–708
Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93–108
Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996
Tanaka S, Louis DN, Curry WT et al (2013) Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol 10:14–26
Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ (2010) Exciting new advances in neurooncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60:166–193
Babae N, Bourajjaj M, Liu Y et al (2014) Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastoma. Oncotarget 5:6687–6700
Chen L, Liu X, Zhang HY et al (2014) Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival. Oncotarget 5:6576–6583
Kim JW, Kim JY, Kim JE et al (2014) HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines. Genes Cancer 5:165–174
Paul I, Bhattacharya S, Chatterjee A,et al (2013) Current understanding on EGFR and Wnt/beta-catenin signaling in glioma and their possible crosstalk. Genes Cancer 4:427–446
Kitanaka C, Sato A, Okada M (2013) JNK signaling in the control of the tumor-initiating capacity associated with cancer stem cells. Genes Cancer 4:388–396
Raemaekers T, Ribbeck K, Beaudouin J et al (2003) NuSAP, a novel microtubule-associated proteininvolved in mitotic spindle organization. J Cell Biol 162:1017–1029
Vanden B, Raemaekers A, Denayer T et al (2010) NuSAP is essential for chromatin-induced spindle formation during early embryogenesis. J Cell Sci 123:3244–3255
Ribbeck K, Groen AC, Santarella R et al (2006) NuSAP, a mitotic RanGTP target that stabilizes and cross-links microtubules. Mol Biol Cell 17:2646–2660
Chen DT, Nasir A, Culhane A et al (2010) Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat 119:335–346
Satow R, Shitashige M, Kanai Y et al (2010) Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res 16:2518–2528
Kokkinakis DM, Liu X, Neuner RD (2005) Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol Cancer Ther 4:1338–1348
Chen Y, Wang Z, Dai X, Fei X, Shen Y, Zhang M, Wang A, Li X, Wang Z, Huang Q, Dong J (2015) Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling. Cancer Lett 365(2):174–181
Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, Zhu YD, Diao Y, Wang AD, Lan Q (2008) Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro. BMC Cancer 8:304
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408
The Cancer Genome Atlas (TCGA) Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068
Hedditch EL, Gao B, Russell AJ et al (2014) ABCA transporter gene expression and poor outcome in epithelial ovarian cancer. J Natl Cancer Inst 106:149
Chen QR, Hu Y, Yan C et al (2014) Systematic genetic analysis identifies Cis-eQTL target genes associated with glioblastoma patient survival. PLoS ONE 9:e105393
Mao P, Hever-Jardine MP, Rahme GJ et al (2013) Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma. PLoS ONE 8:e81803
Brunckhorst MK, Wang H, Lu R et al (2010) Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis. Cancer Res 70:7283–7293
Djaafri I, Khayati F, Menashi S et al (2014) A novel tumor suppressor function of Kindlin-3 in solid cancer. Oncotarget 5:8970–8985
Jiang L, Yang YD, Fu L et al (2014) CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma. Oncotarget 5:7663–7676
Park EY, Chang E, Lee EJ et al (2014) Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance. Cancer Res 74:7573–7582
Sainz B Jr, Martin B, Tatari M et al (2014) ISG15 is a criticalm microenvironmental factor for pancreatic cancer stem cells. Cancer Res 74:7309–7320
Yu H, Ye W, Wu J, Meng X, Liu RY, Ying X et al (2014) Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin Cancer Res 20(13):3434–3445
Erhaak RG, Hoadley KA, Purdom E et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in DGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98–110
Colak D, Nofal A, Albakheet A et al (2013) Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS ONE 8:e63204
Gordon CA, Gulzar ZG, Brooks JD (2015) NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells. Prostate 75:517–526
de la Iglesia N, Konopka G, Puram SV et al (2008) Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev 22:449–462
Acknowledgements
This study was supported by National Natural Science Foundation of China (81472739; 81602183; 81702457), Natural Science Foundation of Jiangsu province, China (BK20151214).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Qian, Z., Li, Y., Ma, J. et al. Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme. J Neurooncol 140, 199–208 (2018). https://doi.org/10.1007/s11060-018-2942-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-018-2942-1